APA (7th ed.) Citation

Falip, M., Miró, J., Jaraba, S., Cusó, S., Capdevila, O., Graus, F., & Martínez-Yélamos, A. (2015). Immunosuppressive therapy for pharmacoresistant epilepsy due to primary antiphospholipid syndrome. Scandinavian Journal of Rheumatology, 44(6), 515. https://doi.org/10.3109/03009742.2015.1041155

Chicago Style (17th ed.) Citation

Falip, M., J. Miró, S. Jaraba, S. Cusó, O. Capdevila, F. Graus, and A. Martínez-Yélamos. "Immunosuppressive Therapy for Pharmacoresistant Epilepsy Due to Primary Antiphospholipid Syndrome." Scandinavian Journal of Rheumatology 44, no. 6 (2015): 515. https://doi.org/10.3109/03009742.2015.1041155.

MLA (9th ed.) Citation

Falip, M., et al. "Immunosuppressive Therapy for Pharmacoresistant Epilepsy Due to Primary Antiphospholipid Syndrome." Scandinavian Journal of Rheumatology, vol. 44, no. 6, 2015, p. 515, https://doi.org/10.3109/03009742.2015.1041155.